Open Access. Powered by Scholars. Published by Universities.®
Circulatory and Respiratory Physiology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Alternative and Complementary Medicine (2)
- Chemicals and Drugs (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Biological Phenomena, Cell Phenomena, and Immunity (1)
-
- Biology (1)
- Body Regions (1)
- COVID-19 (1)
- Cardiovascular System (1)
- Chemical and Pharmacologic Phenomena (1)
- Cognitive Neuroscience (1)
- Cognitive Science (1)
- Communication Sciences and Disorders (1)
- Dance Movement Therapy (1)
- Data Science (1)
- Dentistry (1)
- Endocrine System (1)
- Endodontics and Endodontology (1)
- Equipment and Supplies (1)
- Health Services Research (1)
- Homeopathy (1)
- Investigative Techniques (1)
- Laboratory and Basic Science Research (1)
- Life Sciences (1)
- Medical Biochemistry (1)
- Medical Pharmacology (1)
- Keyword
-
- 432Hz (1)
- 440Hz (1)
- Aneurysm (1)
- Atherosclerosis (1)
- CF (1)
-
- CFTR (1)
- Cardiomyopathy (1)
- Cardiovascular (1)
- Cell Signaling (1)
- Cell Signalling (1)
- Cognitive (1)
- Curcumin (1)
- Cystic Fibrosis (1)
- Elexacaftor (1)
- Emotional (1)
- Frequency (1)
- Genre (1)
- Hertz (1)
- Ivacaftor (1)
- JNK1 (1)
- Lumacaftor (1)
- Modulator (1)
- Music (1)
- NF-kB (1)
- Physiological (1)
- Sound (1)
- Supplementation (1)
- Tezacaftor (1)
- Therapy (1)
- Trikafta (1)
Articles 1 - 3 of 3
Full-Text Articles in Circulatory and Respiratory Physiology
The Science Of Sound: Studying The Cognitive, Emotional, And Physiological Effects Of Frequency, Genre, And Music, Jett Yarborough
The Science Of Sound: Studying The Cognitive, Emotional, And Physiological Effects Of Frequency, Genre, And Music, Jett Yarborough
Senior Honors Theses
Music influences emotion, physiology, and cognition, yet little is known about how the frequency it is tuned to affects these influences. Prior research has shown that music tuned to 432 Hz can reduce stress, lower blood pressure, and improve sleep. My colleagues and I conducted two studies to investigate this. Our research found that music tuned to 432 Hz promotes a significant increase in memory retention and induces a state of focus and relaxation. These results suggest that shifting from the standard tuning frequency of 440 Hz to 432 Hz could have a profoundly positive impact on our daily lives. …
Jnk And Nf-Κb Cell Signaling Pathways In Cardiovascular Disease Present Potential Targets For Curcumin Therapy, Mary Richfield
Jnk And Nf-Κb Cell Signaling Pathways In Cardiovascular Disease Present Potential Targets For Curcumin Therapy, Mary Richfield
Senior Honors Theses
Curcumin (diferuloylmethane) is a compound derived from the rhizomes of Curcumin longa that has been long used for medicinal purposes. Curcumin alleviates the pathology of cardiovascular diseases, including atherosclerosis, aneurysm, and cardiomyopathy. The mechanism of curcumin therapy is under active research. The NF-κB and JNK pathways are two that curcumin interacts with to block inflammatory processes, apoptosis, and fibrotic tissue remodeling to prevent the pathologies of cardiovascular disease. While curcumin has demonstrated powerful mediation of cardiovascular disease, its bioavailability in body tissues is limited due to the instability and hydrophobicity of its structure. Further work is underway to stabilize …
Modulator Therapy For Cystic Fibrosis: An Exploration Of Current Research, Jessalyn Rombocos
Modulator Therapy For Cystic Fibrosis: An Exploration Of Current Research, Jessalyn Rombocos
Senior Honors Theses
Developing a drug therapy that addresses the root cause of cystic fibrosis (CF) by increasing CFTR protein levels has long been a research challenge. After genetic therapy failed because a suitable delivery system could not be found, researchers began searching for small organic molecules that could act as chaperones for CFTR. These molecules, known as modulators, allowed CFTR to be assembled correctly and function similarly to wild type CFTR. Since 2012, four modulator drugs have been developed, tested, and approved by the FDA. In October 2019, Trikafta was approved as the first triple-combination modulator drug and has completely revolutionized CF …